New scanner prototypes aim to improve brain bleed surgery
NCT ID NCT07455201
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests two new Siemens imaging prototypes during minimally invasive surgery to remove brain bleeds. The tools aim to detect leftover bleeding and measure blood flow in the brain. Researchers will compare the prototype images with standard CT scans to see if they are useful. The study involves 15 adults having surgery at Mount Sinai West Hospital.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could improve how doctors see leftover bleeding and blood flow after brain bleed surgery, potentially guiding better treatment.
- What could go wrong
- This is a very small, early feasibility study with only 15 people. The prototypes are still being tested and may not provide clear benefits or change patient outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 15 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2025
- Expected to finish
-
Dec 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patient ≥ 18 years old * Patient is planned to undergo minimally invasive hemorrhage evacuation at Mount Sinai West Hospital Exclusion Criteria: * Patient is \< 18 years old * Patient is not planned to undergo minimally invasive hemorrhage evacuation at Mount Sinai West Hospital
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Intracerebral hemorrhage are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Mount Sinai West
RECRUITINGNew York, New York, 10019, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a web program rebuild memory after brain injury?
- Portable MRI could speed up stroke treatment
- Can a herbal formula match traditional medicine for brain bleeds?
- Can a blood marker tell fever from infection in stroke?
- Can blood markers predict brain injury outcomes?
- Can an ancient herbal pill improve outcomes after a bleeding stroke?